These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 12236625

  • 1. Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine.
    Schmitt GJ, Meisenzahl EM, Dresel S, Tatsch K, Rossmüller B, Frodl T, Preuss UW, Hahn K, Möller HJ.
    J Psychopharmacol; 2002 Sep; 16(3):200-6. PubMed ID: 12236625
    [Abstract] [Full Text] [Related]

  • 2. In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.
    Dresel S, Mager T, Rossmüller B, Meisenzahl E, Hahn K, Möller HJ, Tatsch K.
    Eur J Nucl Med; 1999 Aug; 26(8):862-8. PubMed ID: 10436199
    [Abstract] [Full Text] [Related]

  • 3. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol.
    Tauscher J, Küfferle B, Asenbaum S, Fischer P, Pezawas L, Barnas C, Tauscher-Wisniewski S, Brücke T, Kasper S.
    Psychopharmacology (Berl); 1999 Jan; 141(2):175-81. PubMed ID: 9952042
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia.
    Lavalaye J, Linszen DH, Booij J, Reneman L, Gersons BP, van Royen EA.
    Psychiatry Res; 1999 Nov 08; 92(1):33-44. PubMed ID: 10688158
    [Abstract] [Full Text] [Related]

  • 5. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S, Tatsch K, Dähne I, Mager T, Scherer J, Hahn K.
    J Nucl Med; 1998 Jul 08; 39(7):1138-42. PubMed ID: 9669383
    [Abstract] [Full Text] [Related]

  • 6. Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.
    Pilowsky LS, Busatto GF, Taylor M, Costa DC, Sharma T, Sigmundsson T, Ell PJ, Nohria V, Kerwin RW.
    Psychopharmacology (Berl); 1996 Mar 08; 124(1-2):148-53. PubMed ID: 8935810
    [Abstract] [Full Text] [Related]

  • 7. D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study.
    Meisenzahl EM, Dresel S, Frodl T, Schmitt GJ, Preuss UW, Rossmüller B, Tatsch K, Mager T, Hahn K, Möller HJ.
    J Psychopharmacol; 2000 Mar 08; 14(4):364-70. PubMed ID: 11198054
    [Abstract] [Full Text] [Related]

  • 8. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications.
    Frankle WG, Gil R, Hackett E, Mawlawi O, Zea-Ponce Y, Zhu Z, Kochan LD, Cangiano C, Slifstein M, Gorman JM, Laruelle M, Abi-Dargham A.
    Psychopharmacology (Berl); 2004 Oct 08; 175(4):473-80. PubMed ID: 15083259
    [Abstract] [Full Text] [Related]

  • 9. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone.
    de Haan L, Lavalaye J, Linszen D, Dingemans PM, Booij J.
    Am J Psychiatry; 2000 Jun 08; 157(6):1019-20. PubMed ID: 10831489
    [Abstract] [Full Text] [Related]

  • 10. Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.
    Bernardo M, Parellada E, Lomeña F, Catafau AM, Font M, Gómez JC, López-Carrero C, Gutiérrez F, Pavía J, Salamero M.
    Psychiatry Res; 2001 Aug 25; 107(2):87-97. PubMed ID: 11530275
    [Abstract] [Full Text] [Related]

  • 11. Striatal and temporal cortical D2/D3 receptor occupancy by olanzapine and sertindole in vivo: a [123I]epidepride single photon emission tomography (SPET) study.
    Bigliani V, Mulligan RS, Acton PD, Ohlsen RI, Pike VW, Ell PJ, Gacinovic S, Kerwin RW, Pilowsky LS.
    Psychopharmacology (Berl); 2000 Jun 25; 150(2):132-40. PubMed ID: 10907666
    [Abstract] [Full Text] [Related]

  • 12. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
    Klemm E, Grünwald F, Kasper S, Menzel C, Broich K, Danos P, Reichmann K, Krappel C, Rieker O, Briele B, Hotze AL, Möller HJ, Biersack HJ.
    Am J Psychiatry; 1996 Feb 25; 153(2):183-90. PubMed ID: 8561197
    [Abstract] [Full Text] [Related]

  • 13. Dopamine D2 receptor occupancy by risperidone: implications for the timing and magnitude of clinical response.
    Catafau AM, Corripio I, Pérez V, Martin JC, Schotte A, Carrió I, Alvarez E.
    Psychiatry Res; 2006 Dec 01; 148(2-3):175-83. PubMed ID: 17059881
    [Abstract] [Full Text] [Related]

  • 14. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S, Zipursky RB, Remington G.
    Am J Psychiatry; 1999 Feb 01; 156(2):286-93. PubMed ID: 9989565
    [Abstract] [Full Text] [Related]

  • 15. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J, Hussain T, Agid O, Verhoeff NP, Wilson AA, Houle S, Remington G, Zipursky RB, Kapur S.
    Am J Psychiatry; 2004 Sep 01; 161(9):1620-5. PubMed ID: 15337652
    [Abstract] [Full Text] [Related]

  • 16. In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapine.
    Raedler TJ, Knable MB, Lafargue T, Urbina RA, Egan MF, Pickar D, Weinberger DR.
    Psychiatry Res; 1999 Apr 26; 90(2):81-90. PubMed ID: 10482380
    [Abstract] [Full Text] [Related]

  • 17. Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.
    Meisenzahl EM, Schmitt G, Gründer G, Dresel S, Frodl T, la Fougère C, Scheuerecker J, Schwarz M, Boerner R, Stauss J, Hahn K, Möller HJ.
    Pharmacopsychiatry; 2008 Sep 26; 41(5):169-75. PubMed ID: 18763218
    [Abstract] [Full Text] [Related]

  • 18. Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study.
    Lavalaye J, Booij J, Linszen DH, Reneman L, van Royen EA.
    Psychopharmacology (Berl); 2001 Jun 26; 156(1):53-7. PubMed ID: 11465633
    [Abstract] [Full Text] [Related]

  • 19. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
    Bressan RA, Erlandsson K, Jones HM, Mulligan R, Flanagan RJ, Ell PJ, Pilowsky LS.
    Am J Psychiatry; 2003 Aug 26; 160(8):1413-20. PubMed ID: 12900302
    [Abstract] [Full Text] [Related]

  • 20. Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia.
    Paquet F, Soucy JP, Stip E, Lévesque M, Elie A, Bédard MA.
    J Neuropsychiatry Clin Neurosci; 2004 Aug 26; 16(1):47-56. PubMed ID: 14990759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.